- Home
- ELTK vs IKNA Comparison
ELTK vs IKNA Comparison
Compare ELTK & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTK
- IKNA
- Stock Information
- Founded
- ELTK 1970
- IKNA 2016
- Country
- ELTK Israel
- IKNA United States
- Employees
- ELTK N/A
- IKNA N/A
- Industry
- ELTK Electrical Products
- IKNA Biotechnology: Pharmaceutical Preparations
- Sector
- ELTK Technology
- IKNA Health Care
- Exchange
- ELTK Nasdaq
- IKNA Nasdaq
- Market Cap
- ELTK 69.5M
- IKNA 61.8M
- IPO Year
- ELTK 1997
- IKNA 2021
- Fundamental
- Price
- ELTK $10.26
- IKNA $1.34
- Analyst Decision
- ELTK
- IKNA Strong Buy
- Analyst Count
- ELTK 0
- IKNA 1
- Target Price
- ELTK N/A
- IKNA $4.00
- AVG Volume (30 Days)
- ELTK 29.9K
- IKNA 71.8K
- Earning Date
- ELTK 08-14-2025
- IKNA 08-07-2025
- Dividend Yield
- ELTK 1.77%
- IKNA N/A
- EPS Growth
- ELTK N/A
- IKNA N/A
- EPS
- ELTK 0.51
- IKNA N/A
- Revenue
- ELTK $47,500,000.00
- IKNA N/A
- Revenue This Year
- ELTK $18.60
- IKNA N/A
- Revenue Next Year
- ELTK $9.04
- IKNA N/A
- P/E Ratio
- ELTK $20.83
- IKNA N/A
- Revenue Growth
- ELTK 1.05
- IKNA N/A
- 52 Week Low
- ELTK $7.65
- IKNA $0.97
- 52 Week High
- ELTK $12.19
- IKNA $1.94
- Technical
- Relative Strength Index (RSI)
- ELTK 60.50
- IKNA 54.06
- Support Level
- ELTK $10.27
- IKNA $1.31
- Resistance Level
- ELTK $10.97
- IKNA $1.37
- Average True Range (ATR)
- ELTK 0.63
- IKNA 0.05
- MACD
- ELTK 0.03
- IKNA -0.01
- Stochastic Oscillator
- ELTK 63.66
- IKNA 26.85
About ELTK Eltek Ltd.
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.